Syed M Zaidi, MD | |
2700 Martin Luther King Jr. Ave,, Saint Elizabeths Hospital-rmb Building,room 1w 25, Washington Dc, Se, DC 20032 | |
(202) 645-7551 | |
Not Available |
Full Name | Syed M Zaidi |
---|---|
Gender | Male |
Speciality | Internal Medicine - Cardiovascular Disease |
Location | 2700 Martin Luther King Jr. Ave,, Washington Dc, Se, District Of Columbia |
Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1538372503 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | MD 15116 (District Of Columbia) | Primary |
Mailing Address | Practice Location Address |
---|---|
Syed M Zaidi, MD 3505 Pinetree Terrace, Falls Church, VA 22041 Ph: (202) 365-6136 | Syed M Zaidi, MD 2700 Martin Luther King Jr. Ave,, Saint Elizabeths Hospital-rmb Building,room 1w 25, Washington Dc, Se, DC 20032 Ph: (202) 645-7551 |
News Archive
An estimated 200,000 Americans experience TIAs each year, and more than one-third will later have full strokes. But TIAs, like strokes, are treatable and preventable.
Rexahn Pharmaceuticals, Inc. has announced that it has received FDA approval to begin Phase II trials for Archexin, the Company's leading cancer compound, for the treatment of pancreatic cancer.
The U.S. Centers for Disease Control and Prevention has awarded $15.88 million to the Wayne State University School of Medicine's Department of Emergency Medicine to be the epicenter of a national study on viral infections that present in emergency departments across the county.
A common drug that is used to treat high blood pressure in the general population has been found to significantly reduce a dangerous and frequently fatal cardiac problem in patients with Marfan syndrome.
New research published in the December issue of the Journal of the American College of Surgeons finds that the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) is a powerful tool for assessing outcomes of uncommon, high-risk surgical procedures, including pancreatic necrosectomy.
› Verified 7 days ago